Softwr

Healthcare · head to head

Epocrates vs Ibex Medical Analytics

Epocrates logo

Epocrates

Healthcare

Mobile clinical reference and decision support app

From
Free
Rated
-
Ibex Medical Analytics logo

Ibex Medical Analytics

Healthcare

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots

From
On request
Rated
-

The short version

  • Only Epocrates has a free tier, so it costs nothing to try first.
  • Each has a real cost: Epocrates pricing page not publicly accessible; Ibex Medical Analytics the European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • They diverge on capability: Epocrates covers Drug Reference, Ibex Medical Analytics covers Ibex Breast Suite.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Epocrates and Ibex Medical Analytics actually diverge.

Attributes where Epocrates and Ibex Medical Analytics differ
AttributeEpocratesIbex Medical Analytics
Starting priceFreeOn request
Pricing modelfreemiumquote
Free tierYesNo
PlatformsMobileWeb, Cloud, On-premise
Founded2000Unknown

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Epocrates

  • Drug Reference
  • Interactions
  • Dosing Calculators
  • Disease Information
  • Medical Procedures
  • Patient Education
  • EHR Systems
  • HIPAA

Only in Ibex Medical Analytics

  • Ibex Breast Suite
  • Ibex Prostate
  • Ibex Gastric
  • Second read safety net
  • Prescreening triage
  • Heatmap localisation
  • Quality reporting
  • Scanner-agnostic ingestion

What people use each for

The jobs each tool is most often brought in to do.

Epocrates

  • Patient Carenot Ibex Medical Analytics
  • Medical Recordsnot Ibex Medical Analytics
  • Practice Managementnot Ibex Medical Analytics
  • Telehealthnot Ibex Medical Analytics

Ibex Medical Analytics

  • A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign outnot Epocrates
  • A private laboratory group standardising Gleason grading across pathologists with known interobserver variabilitynot Epocrates
  • A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its boardnot Epocrates
  • A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic casesnot Epocrates

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Epocrates

  • Pricing page not publicly accessible

Ibex Medical Analytics

  • The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
  • Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
  • Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
  • Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.

Pricing, plan by plan

Epocrates

Free
  • FreeFree
    • Drug references
    • Calculators
    • Interactions
  • Premium$99/year
    • Enhanced content
    • Offline access

Ibex Medical Analytics

On request
  • Ibex clinical applications$undefined/year
    • Priced per case analysed under an annual agreement
    • Breast, prostate and gastric licensed as separate suites
    • Regulatory indication differs between Europe and the United States

Which should you pick?

Choose Epocrates if

  • You need drug reference.
  • You want to start without paying.
  • You work on Mobile.
  • You also want interactions.

Choose Ibex Medical Analytics if

  • You need ibex breast suite.
  • You work on Web, Cloud, On-premise.
  • You also want ibex prostate.

Questions people ask

Is Epocrates or Ibex Medical Analytics better?
Neither clearly leads. Epocrates starts at Free and Ibex Medical Analytics at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Epocrates or Ibex Medical Analytics?
Epocrates has a free tier; the other does not. Paid plans start at Free for Epocrates and On request for Ibex Medical Analytics.
Does Epocrates or Ibex Medical Analytics run on more platforms?
Epocrates runs on Mobile. Ibex Medical Analytics runs on Web, Cloud, On-premise.
Can I use Epocrates for free?
Yes. Epocrates has a free tier, so you can try it without paying. Ibex Medical Analytics starts at On request.
What is Epocrates best used for?
Epocrates is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Ibex Medical Analytics is typically brought in for.
What can Epocrates do that Ibex Medical Analytics cannot?
Epocrates covers Drug Reference, Interactions, Dosing Calculators, Disease Information. Ibex Medical Analytics covers Ibex Breast Suite, Ibex Prostate, Ibex Gastric, Second read safety net.

Answered from the vendors’ own pages

Epocrates: How much does Epocrates cost?

Epocrates pricing information is not available to public access. Users must authenticate or contact the vendor to view pricing details.

Source
Ibex Medical Analytics: Is Ibex FDA cleared?

The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.

Ibex Medical Analytics: Second read or prescreening?

Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.

Ibex Medical Analytics: Does it need a particular scanner?

It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.

Ibex Medical Analytics: What tissue types are covered?

Breast, prostate and gastric. Everything else in the case mix is unsupported.

Share

Related pages

Other head to heads